Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Acute Kidney Injury D058186 34 associated lipids
Airway Remodeling D056151 3 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Hypoalphalipoproteinemias D052456 5 associated lipids
Atherosclerosis D050197 85 associated lipids
Dyslipidemias D050171 7 associated lipids
Cholecystitis, Acute D041881 1 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Coronary Stenosis D023921 6 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Stroke D020521 32 associated lipids
Latex Hypersensitivity D020315 1 associated lipids
Intracranial Hemorrhage, Hypertensive D020299 1 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Venous Thrombosis D020246 11 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Carotid Artery Injuries D020212 8 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Basal Ganglia Hemorrhage D020145 1 associated lipids
Thrombophilia D019851 6 associated lipids
Endotoxemia D019446 27 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Atrial Premature Complexes D018880 1 associated lipids
Sepsis D018805 11 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Osteoblastoma D018215 1 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Hypertrophy, Left Ventricular D017379 12 associated lipids
beta-Thalassemia D017086 5 associated lipids
Carotid Stenosis D016893 15 associated lipids
Death, Sudden, Cardiac D016757 12 associated lipids
Yang Deficiency D016711 3 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Helicobacter Infections D016481 21 associated lipids
Bacteremia D016470 9 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Weight Loss D015431 56 associated lipids
Weight Gain D015430 101 associated lipids
Myocardial Reperfusion Injury D015428 20 associated lipids
Reperfusion Injury D015427 65 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Wounds and Injuries D014947 20 associated lipids
Weil Disease D014895 2 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Vitamin E Deficiency D014811 29 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Badesch DB et al. Decreased arterial wall prostaglandin production in neonatal calves with severe chronic pulmonary hypertension. 1989 Am. J. Respir. Cell Mol. Biol. pmid:2517777
Shellito J and Sniezek M Altered release of eicosanoids by rat alveolar macrophages during granulomatous pulmonary inflammation. 1990 Am. J. Respir. Cell Mol. Biol. pmid:2155633
Sayers BC et al. Role of cyclooxygenase-2 in exacerbation of allergen-induced airway remodeling by multiwalled carbon nanotubes. 2013 Am. J. Respir. Cell Mol. Biol. pmid:23642096
Ciabattoni G et al. In vivo lipid peroxidation and platelet activation in cystic fibrosis. 2000 Am. J. Respir. Crit. Care Med. pmid:11029317
Mitra A et al. Thromboxane-mediated alveolar responses to acute obstruction of the pulmonary vasculature. 1997 Am. J. Respir. Crit. Care Med. pmid:9117035
Vass G et al. Comparison of nasal and oral inhalation during exhaled breath condensate collection. 2003 Am. J. Respir. Crit. Care Med. pmid:12493648
Okazawa A et al. 8-Epi-PGF2alpha induces airflow obstruction and airway plasma exudation in vivo. 1997 Am. J. Respir. Crit. Care Med. pmid:9032175
Pavord ID et al. Induced sputum eicosanoid concentrations in asthma. 1999 Am. J. Respir. Crit. Care Med. pmid:10588604
Kataoka M et al. A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension. 2005 Am. J. Respir. Crit. Care Med. pmid:16192456
Snapper JR et al. Role of endothelin in endotoxin-induced sustained pulmonary hypertension in sheep. 1998 Am. J. Respir. Crit. Care Med. pmid:9445282
Chen CR et al. Platelet-activating factor potentiates protamine-induced lung edema. Role of eicosanoids. 1994 Am. J. Respir. Crit. Care Med. pmid:8111595
Jankov RP et al. Thromboxane A(2) receptors mediate pulmonary hypertension in 60% oxygen-exposed newborn rats by a cyclooxygenase-independent mechanism. 2002 Am. J. Respir. Crit. Care Med. pmid:12119234
Gust R et al. Role of cyclooxygenase-2 in oleic acid-induced acute lung injury. 1999 Am. J. Respir. Crit. Care Med. pmid:10508803
Mayer K et al. Acute lung injury is reduced in fat-1 mice endogenously synthesizing n-3 fatty acids. 2009 Am. J. Respir. Crit. Care Med. pmid:19136374
Gust R et al. Synergistic hemodynamic effects of low-dose endotoxin and acute lung injury. 1998 Am. J. Respir. Crit. Care Med. pmid:9620928
O'Connor BJ et al. Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans. 1994 Am. J. Respir. Crit. Care Med. pmid:8025768
Davì G et al. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group. 1997 Am. J. Respir. Crit. Care Med. pmid:9412557
Jiang XW et al. Effects of low-dose Beraprost sodium, a stable prostaglandin I2 analogue, on reperfusion injury to rabbit lungs. 1998 Am. J. Respir. Crit. Care Med. pmid:9817723
Praticò D et al. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. 1998 Am. J. Respir. Crit. Care Med. pmid:9847257
Gust R et al. Response to inhaled nitric oxide in acute lung injury depends on distribution of pulmonary blood flow prior to its administration. 1999 Am. J. Respir. Crit. Care Med. pmid:9927374
Imai Y et al. Inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation. 1994 Am. J. Respir. Crit. Care Med. pmid:7952613
Degges RD et al. Pulmonary hypertensive effect of heparin and protamine interaction: evidence for thromboxane B2 release from the lung. 1987 Am. J. Surg. pmid:3425821
Myers SI and Hernandez R Leukotriene C4 regulation of splanchnic blood flow during ischemia. 1994 Am. J. Surg. pmid:8209929
O'Neill PA et al. Role of renal sympathetic nerve activity in renal failure associated with obstructive jaundice in the rat. 1991 Am. J. Surg. pmid:1862825
Tanowitz HB et al. Enhanced platelet adherence and aggregation in Chagas' disease: a potential pathogenic mechanism for cardiomyopathy. 1990 Am. J. Trop. Med. Hyg. pmid:2121055
Brideau C et al. In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats. 2001 Am. J. Vet. Res. pmid:11703020
MacKay RJ et al. Effect of a conjugate of polymyxin B-dextran 70 in horses with experimentally induced endotoxemia. 1999 Am. J. Vet. Res. pmid:9918150
Giraudel JM et al. Development of in vitro assays for the evaluation of cyclooxygenase inhibitors and predicting selectivity of nonsteroidal anti-inflammatory drugs in cats. 2005 Am. J. Vet. Res. pmid:15900953
Grauer GF et al. Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs. 1996 Am. J. Vet. Res. pmid:8725828
Morris DD et al. Proadifen-induced production of prostacyclin by equine peritoneal macrophages. 1989 Am. J. Vet. Res. pmid:2499232
Morris DD et al. Endotoxin-induced changes in plasma concentrations of thromboxane and prostacyclin in neonatal calves given antiserum to a mutant Escherichia coli (J-5). 1986 Am. J. Vet. Res. pmid:3541703
Hoh CM et al. Evaluation of effects of low-dose aspirin administration on urinary thromboxane metabolites in healthy dogs. 2011 Am. J. Vet. Res. pmid:21801060
Semrad SD et al. Pharmacokinetics of and serum thromboxane suppression by flunixin meglumine in healthy foals during the first month of life. 1993 Am. J. Vet. Res. pmid:8116942
Gerros TC et al. Effect of dose and method of administration of endotoxin on cell mediator release in neonatal calves. 1993 Am. J. Vet. Res. pmid:8116949
Longhofer SL et al. Effects of a specific thromboxane synthetase inhibitor on thromboxane generation and excretion in healthy dogs. 1990 Am. J. Vet. Res. pmid:2240799
Pratt HL et al. Platelet aggregation, storage pool deficiency, and protein phosphorylation in mice with Chediak-Higashi syndrome. 1991 Am. J. Vet. Res. pmid:1652907
Baskett A et al. Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses. 1997 Am. J. Vet. Res. pmid:9361895
Barton MH et al. Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin. 1997 Am. J. Vet. Res. pmid:9361896
Kay-Mugford T and Conlon P Possible inconsistencies in study on cyclooxygenase. 1999 Am. J. Vet. Res. pmid:10188806
Davidson MG et al. Vascular permeability and coagulation during Rickettsia rickettsii infection in dogs. 1990 Am. J. Vet. Res. pmid:2105679
Gershwin LJ and Giri SN Effects of allergen challenge on plasma concentrations of prostaglandins, thromboxane B2, and histamine in calves infected with bovine respiratory syncytial virus. 1992 Am. J. Vet. Res. pmid:1416375
Semrad SD et al. Effects of concurrent administration of phenylbutazone and flunixin meglumine on pharmacokinetic variables and in vitro generation of thromboxane B2 in mares. 1993 Am. J. Vet. Res. pmid:8291770
Semrad SD et al. Pharmacokinetics and effects of repeated administration of phenylbutazone in neonatal calves. 1993 Am. J. Vet. Res. pmid:8291771
Wooten JG et al. Cyclooxygenase expression and prostanoid production in pyloric and duodenal mucosae in dogs after administration of nonsteroidal anti-inflammatory drugs. 2008 Am. J. Vet. Res. pmid:18380576
Cargile JL et al. Effects of tumor necrosis factor blockade on interleukin 6, lactate, thromboxane, and prostacyclin responses in miniature horses given endotoxin. 1995 Am. J. Vet. Res. pmid:8585654
Baxter GM and Moore JN Effect of aspirin on ex vivo generation of thromboxane in healthy horses. 1987 Am. J. Vet. Res. pmid:3826831
Grauer GF et al. Effects of a thromboxane synthetase inhibitor on established immune complex glomerulonephritis in dogs. 1992 Am. J. Vet. Res. pmid:1388004
Ricketts AP et al. Evaluation of selective inhibition of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs. 1998 Am. J. Vet. Res. pmid:9829404
Cook VL et al. Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum. 2009 Am. J. Vet. Res. pmid:19645580
Arifah AK et al. Pharmacodynamics and pharmacokinetics of ketoprofen enantiomers in sheep. 2001 Am. J. Vet. Res. pmid:11197566